The ASPIRE Award program aims to identify and support innovative clinical research projects focused on gaining a greater insight into primary and secondary immunodeficiency diseases.
It provides financial support to young scientists and clinicians who wish to undertake a research project that seeks to improve immunodeficiency awareness, diagnosis and immunoglobulin therapy.
Grifols is proud of the ASPIRE Award program and believes it demonstrates the company's commitment to ongoing innovation in this field of scientific endeavor. Hopefully, the program will ultimately contribute to improving standards of care and delivering a brighter future for patients with immunodeficiency.
Application process for the ASPIRE Award 2021 closed.
The awardee will be announced in July 2021.
Applications for the next edition 2022 will be accepted between 4 October 2021 and 31 March 2022.